Bio Solution Co.,Ltd. (KOSDAQ:086820)

Market Cap	205.95B -9.0%
Revenue (ttm)	8.27B -6.8%
Net Income	-1.28B
EPS	-53.69
Shares Out	24.17M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	157,049
Average Volume	449,674
Open	12,180
Previous Close	12,460
Day's Range	12,150 - 12,790
52-Week Range	7,050 - 13,450
Beta	0.41
RSI	71.35
Earnings Date	Mar 24, 2026

About Bio Solution

Bio Solution Co.,Ltd. develops, manufactures, and sells cell therapy products worldwide. The company offers CartiLife, an autologous chondrocyte cell-based therapy for the restoration of symptomatic and structural complications caused by articular cartilage defects; KeraHeal-Allo, a thermosensitive hydrogel-type allogenic keratinocyte cell-therapy product to promote re-epithelialization of deep 2nd-degree burn wounds; and KeraHeal, an autologous spray-type keratinocyte cell-based therapy for skin wounds. It also provides reconstructed human mic...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2000
• Employees: 71
• Stock Exchange: KOSDAQ
• Ticker Symbol: 086820